Bharat Immunologicals Shares Outstanding

BIBCL -- India Stock  

INR 21.35  1.60  8.10%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
Symbol
Refresh

Shares Outstanding Analysis

Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted bases which include exotic instruments such as options, or convertibles bonds.
Bharat Immunologicals 
Shares Outstanding 
 = 
Public Shares 
Repurchased 
 = 
43.18 M

About Shares Outstanding

Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Compare to competition
Based on latest financial disclosure Bharat Immunologicals Biologicals Corp Ltd has 43.18 M of shares currently outstending. This is much higher than that of the Healthcare sector, and significantly higher than that of Shares Outstanding industry, The Shares Outstanding for all stocks is over 1000% lower than the firm.

Peer Comparison

Bharat Immunologicals Shares Outstanding Comparison
Bharat Immunologicals is currently under evaluation in shares outstanding category among related companies.

Did you try this?

Run Chance of Distress Now
   

Chance of Distress

Get analysis of equity chance of financial distress in the next 2 years
All  Next Launch Chance of Distress

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Fundamental Indicators

Current Bharat Immunologicals financial ratios